The global ambulatory surgery centers market size was estimated at USD 124.44 billion in 2023 and is projected to hit around USD 226.89 billion by 2033, growing at a CAGR of 6.19% during the forecast period from 2024 to 2033.
Key Takeaways:
Ambulatory Surgery Centers Market Growth
Key drivers include an increase in the incidence of chronic diseases and a rise in the geriatric population, which requires cost-effective and efficient treatment. Furthermore, advancements in diagnostic techniques and surgeries, such as minimally invasive surgeries, endoscopy, and laparoscopy, are expected to drive market growth.
The market for ambulatory surgery centers (ASCs) is poised to witness significant growth in the coming years. The cost-effectiveness of procedures performed at ASCs has made them appealing to patients and healthcare providers. Furthermore, the rising geriatric population contributes to the growing demand for surgeries and is expected to fuel market expansion. According to a report from the Ambulatory Surgery Center Association, the availability and utilization of ambulatory surgery centers have led to a reduction of annual healthcare costs in the United States by USD 38 billion. This demonstrates the positive impact of ASCs on healthcare affordability and accessibility.
Moreover, healthcare expenditure in ambulatory surgery centers is significantly lower than in hospitals. An extensive report by OR Manager , based on CMS statistics from January 2020, stated that 57 billion surgical procedures are performed in the U.S. every year. Less than 20% of these procedures are estimated to be done in inpatient hospital facilities, which indicates a shift in demand toward ambulatory surgery centers.The lower healthcare expenditure associated with ASCs has contributed to their increasing popularity. It has led to a significant transformation in the healthcare landscape, with more patients opting for outpatient procedures in these specialized facilities.
The COVID-19 pandemic positively impacted ASCs due to the increased demand for emergency care and the number of COVID-19-positive patients. According to an article by the National Center of Biotechnology Information in May 2022, ambulatory surgical centers and other facilities that perform surgeries and procedures were advised to comply with guidance to prevent the spread of COVID-19 and to protect resources such as bed space, staffing, personal protective equipment, and ventilators needed to care for COVID-19 patients. In addition, in April 2020, the Centers for Medicare and Medicaid Services (CMS) laid out a process to temporarily enroll Medicare-approved ASFs as hospitals during the COVID-19 public health emergency.
Major players in the healthcare industry are undertaking strategic initiatives to increase their market share through the acquisition of medical practices and outpatient facilities. These initiatives are aimed at expanding their reach and enhancing their service offerings. For instance, in February 2022, Mayo Clinic announced plans for a USD 432 million expansion to modify an existing facility in Jacksonville, Florida by adding 121 new inpatient beds. Such investments are expected to drive market growth.
Ambulatory Surgery Centers Market Report Scope
Report Attribute | Details |
Market Size in 2024 | USD 132.15 Billion |
Market Size by 2033 |
USD 226.89 Billion |
Growth Rate From 2024 to 2033 | CAGR of 6.19% |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | Application, ownership, center type, region |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Key Companies Profiled | CHSPSC, LLC.; Envision Healthcare Corporation; TH Medical; Pediatrix Medical Group; UNITEDHEALTH GROUP; Surgery Partners; Healthway Medical Group; SurgCenter; Prospect Medical Holdings, Inc.; Group Eifelhöhen-Klinik AG; Edward-Elmhurst Health; Nexus Day Surgery Centre |
Application Insights
The orthopedics segment led the global market in 2023 with a revenue share of 28.45%. This strong demand is attributed to the increasing need for orthopedic surgery and the growing number of strategic initiatives by major market players. In recent years, the number of knee and hip replacement surgeries has increased steadily, positively impacting the growth of this segment.
For instance, a June 2021 Canadian Health Information Institute report showed that 55,300 hip replacements and 55,285 knee replacements were performed in Canada during 2020-2021. Additionally, knee and hip replacement surgeries have increased by an average of about 5% in recent years in these countries.Hence, the demand for ambulatory surgery centers is expected to increase due to the high number of orthopedic surgeries, thus fueling segment growth.
Based on application, the market is segmented into pain management/spinal injections, orthopedics, ophthalmology, gastroenterology, plastic surgery, otolaryngology, obstetrics/gynecology, dental, podiatry, and others. The pain management/spinal injections segment is expected to witness strong growth over the forecast period. Pain management services include the treatment and assessment of persistent pain. Rapid recovery, early discharge, and low chances of requirement of surgeries, as well as minimum adverse effects of anesthesia, such as fatigue, nausea, and pain, are among the factors driving segment growth.
Center Type Insights
The single-specialty segment dominated the ambulatory surgery centers market in 2023 with a revenue share of 62.78%. The increased incidence and frequency of ocular disorders and the growing number of single specialty ambulatory surgery centers are factors attributed to market growth. For instance, as of June 2023, according to ASC Data, the number of single-specialty ambulatory surgical centers in the U.S. stood at 3,082.
Hernia repair, knee replacements, colonoscopy, and other less-intrusive treatments are among the surgeries carried out in single-specialty ambulatory surgical centers. These establishments must follow strict guidelines and criteria for patient safety and care quality. Furthermore, the reimbursement rate for procedures at these facilities is high. Hence, the market for single-specialty ambulatory surgical centers is growing rapidly.
Based on the center type, the market is segmented into single-specialty and multi-specialty. The multi-specialty segment is anticipated to develop at the fastest rate through the projection period, due to its broad and patient-focused strategy for surgical treatment, bringing a variety of services under a single roof and helping medical procedures run more smoothly. Increased surgical procedures in fields such as gastroenterology, pain management, and ophthalmology are anticipated to drive revenue in the multi-specialty segment.
Ownership Insights
The physician-owned segment dominated the market in 2023 with a revenue share of 63.17%. This is owing to advantages such as the chance to communicate directly with medical professionals who are familiar with each patient's situation and the capability to completely focus on a small number of treatments in a single environment. The increase in revenue in this segment is anticipated to be fueled by reduced surgical operation expenses compared to other ambulatory surgery facilities, favorable reimbursements, low operating expenses, and other associated variables. Based on ownership, the market is segmented into physician-owned, hospital-owned, and corporate-owned.
The hospital-owned segment is poised to expand at the fastest pace through the forecast period, due to a rising shift of patients from inpatient healthcare facilities to hospital-owned ambulatory surgery facilities. Key players are launching various programs through partnerships to aid market growth. For instance, in November 2021, an innovative total joint program was introduced by the Effingham Ambulatory Surgery Center, which is a joint venture partner of Sarah Bush Lincoln Health System (SBLHS) and an affiliate of USPI (United Surgical Partners International). The patient receives individualized support through this initiative from the moment the surgery is scheduled until they have recovered from the operation. Such initiatives help raise the standard of care provided.
Regional Insights
North America contributed significantly to the market in 2023 with a revenue share of around 36.28%. This can be attributed to the rapid adoption of technologically developed products in the region. Increasing government support for primary care and expansion of outpatient care are the major factors for the expansion of the ambulatory surgical center market in the North America region.
Increasing government initiatives and strategic undertakings by key market players are expected to drive the regional market. In March 2021, Ascension, a prominent healthcare organization, entered into a partnership agreement with Regent Surgical Health, a leading developer of ambulatory surgery centers (ASCs). This collaboration aims to facilitate the development, acquisition, and operation of ambulatory surgery centers in the communities served by Ascension. The primary objective of this initiative is to offer patients convenient access to high-quality outpatient surgical services.
On the other hand, Asia Pacific is expected to register the fastest growth over the coming years. The expansion of outpatient facilities is driven by rising healthcare costs, along with the growing prevalence of chronic diseases, an aging population, and rising hospitalization rates, which have led to increased demand for ambulatory services in the region.
Key Companies & Market Share Insights
The market is competitive owing to the presence of several ambulatory surgery center providers. Market players are adopting various strategies, such as new service launches, partnerships & collaborations, and regional expansion to gain higher shares. For instance, in February 2023, Spire Orthopedic Partners partnered with Dutchess County Orthopedic Associates, making Spire one of the largest orthopedic platforms in the United States. This will enable the company to serve existing patients better and meet the increasing demand.
In July 2022, the Southeastern Spine Institute Ambulatory Surgery Center, an affiliate of United Surgical Partners International, introduced a robotic surgery program. The center is equipped with advanced robotic systems to improve the accuracy and effectiveness of total knee replacement surgery. Additionally, in January 2022, ValueHealth LLC announced that its JV partner Penn State Health had acquired shares in the Surgery Center of Lancaster.Some of the prominent players in the global ambulatory surgery centers market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the Ambulatory Surgery Centers market.
By Application
By Ownership
By Center Type
By Region
Chapter 1. Ambulatory Surgery Centers Market: Methodology And Scope
1.1. Market Segmentation And Scope
1.1.1. Segment Definitions
1.1.1.1. Application Segment
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. nova one advisor Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.8.1. Model Details
1.9. Commodity Flow Analysis
1.10. Volume Price Analysis
1.11. List Of Secondary Sources
1.12. List Of Abbreviations
Chapter 2. Ambulatory Surgery Centers Market: Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Ambulatory Surgery Centers Market: Variables, Trends, & Scope
3.1. Market Segmentation And Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends And Outlook
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Cost-Effective Alternative
3.4.1.2. Technological Advancements And Increasing Demand For Minimally Invasive Surgeries
3.4.2. Market Restraint Analysis
3.4.2.1. Operational Uncertainty
3.4.2.2. Regulatory Concerns Associated With Outpatient Care
3.5. Business Environment Analysis
3.5.1. PESTLE Analysis
3.5.2. Porter’s Five Forces Analysis
3.6. COVID-19 Impact Analysis
Chapter 4. Ambulatory Surgery Centers Market: Application Analysis
4.1. Ambulatory Surgery Centers Market: Application Movement Analysis
4.2. Orthopedics
4.2.1. Orthopedics Market, 2021 - 2033
4.3. Pain Management/Spinal Injections
4.3.1. Pain Management/Spinal Injections Market, 2021 - 2033
4.4. Gastroenterology
4.4.1. Gastroenterology Market, 2021 - 2033
4.5. Ophthalmology
4.5.1. Ophthalmology Market, 2021 - 2033
4.6. Plastic Surgery
4.6.1. Plastic Surgery Market, 2021 - 2033
4.7. Otolaryngology
4.7.1. Otolaryngology Market, 2021 - 2033
4.8. Obstetrics/Gynecology
4.8.1. Obstetrics/Gynecology Market, 2021 - 2033
4.9. Dental
4.9.1. Dental Market, 2021 - 2033
4.10. Podiatry
4.10.1. Podiatry Market, 2021 - 2033
4.11. Others
4.11.1. Other Applications Market, 2021 - 2033
Chapter 5. Ambulatory Surgery Centers Market: Ownership Analysis
5.1. Ambulatory Surgery Centers Market: Ownership Movement Analysis
5.2. Physician-Owned
5.2.1. Physician-Owned Market, 2021 - 2033
5.3. Hospital-Owned
5.3.1. Hospital-Owned Market, 2021 - 2033
5.4. Corporate-Owned
5.4.1. Corporate-Owned Market, 2021 - 2033
Chapter 6. Ambulatory Surgery Centers Market: Center Type Analysis
6.1. Ambulatory Surgery Centers Market: Center Type Movement Analysis
6.2. Single-Specialty
6.2.1. Single-Specialty Market, 2021 - 2033
6.3. Multi-Specialty
6.3.1. Multi-Specialty Market, 2021 - 2033
Chapter 7. Ambulatory Surgery Centers Market: Regional Analysis
7.1. Ambulatory Surgery Centers Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. North America Ambulatory Surgery Centers Market, 2021 - 2033
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Regulatory Framework & Reimbursement Scenario
7.2.2.3. Competitive Scenario
7.2.2.4. U.S. Ambulatory Surgery Centers Market, 2021 - 2033
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Regulatory Framework & Reimbursement Scenario
7.2.3.3. Competitive Scenario
7.2.3.4. Canada Ambulatory Surgery Centers Market, 2021 - 2033
7.3. Europe
7.3.1. Europe Ambulatory Surgery Centers Market, 2021 - 2033
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Regulatory Framework & Reimbursement Scenario
7.3.2.3. Competitive Scenario
7.3.2.4. UK Ambulatory Surgery Centers Market, 2021 - 2033
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Regulatory Framework & Reimbursement Scenario
7.3.3.3. Competitive Scenario
7.3.3.4. Germany Ambulatory Surgery Centers Market, 2021 - 2033
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Regulatory Framework & Reimbursement Scenario
7.3.4.3. Competitive Scenario
7.3.4.4. France Ambulatory Surgery Centers Market, 2021 - 2033
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Regulatory Framework & Reimbursement Scenario
7.3.5.3. Competitive Scenario
7.3.5.4. Italy Ambulatory Surgery Centers Market, 2021 - 2033
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Regulatory Framework & Reimbursement Scenario
7.3.6.3. Competitive Scenario
7.3.6.4. Spain Ambulatory Surgery Centers Market, 2021 - 2033
7.3.7. Sweden
7.3.7.1. Key Country Dynamics
7.3.7.2. Regulatory Framework & Reimbursement Scenario
7.3.7.3. Competitive Scenario
7.3.7.4. Sweden Ambulatory Surgery Centers Market, 2021 - 2033
7.3.8. Norway
7.3.8.1. Key Country Dynamics
7.3.8.2. Regulatory Framework & Reimbursement Scenario
7.3.8.3. Competitive Scenario
7.3.8.4. Norway Ambulatory Surgery Centers Market, 2021 - 2033
7.3.9. Denmark
7.3.9.1. Key Country Dynamics
7.3.9.2. Regulatory Framework & Reimbursement Scenario
7.3.9.3. Competitive Scenario
7.3.9.4. Denmark Ambulatory Surgery Centers Market, 2021 - 2033
7.4. Asia Pacific
7.4.1. Asia Pacific Ambulatory Surgery Centers Market, 2021 - 2033
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Regulatory Framework & Reimbursement Scenario
7.4.2.3. Competitive Scenario
7.4.2.4. Japan Ambulatory Surgery Centers Market, 2021 - 2033
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Regulatory Framework & Reimbursement Scenario
7.4.3.3. Competitive Scenario
7.4.3.4. China Ambulatory Surgery Centers Market, 2021 - 2033
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Regulatory Framework & Reimbursement Scenario
7.4.4.3. Competitive Scenario
7.4.4.4. India Ambulatory Surgery Centers Market, 2021 - 2033
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Regulatory Framework & Reimbursement Scenario
7.4.5.3. Competitive Scenario
7.4.5.4. Australia Ambulatory Surgery Centers Market, 2021 - 2033
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Regulatory Framework & Reimbursement Scenario
7.4.6.3. Competitive Scenario
7.4.6.4. Thailand Ambulatory Surgery Centers Market, 2021 - 2033
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Regulatory Framework & Reimbursement Scenario
7.4.7.3. Competitive Scenario
7.4.7.4. South Korea Ambulatory Surgery Centers Market, 2021 - 2033
7.5. Latin America
7.5.1. Latin America Ambulatory Surgery Centers Market, 2021 - 2033
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Regulatory Framework & Reimbursement Scenario
7.5.2.3. Competitive Scenario
7.5.2.4. Brazil Ambulatory Surgery Centers Market, 2021 - 2033
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Regulatory Framework & Reimbursement Scenario
7.5.3.3. Competitive Scenario
7.5.3.4. Mexico Ambulatory Surgery Centers Market, 2021 - 2033
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Regulatory Framework & Reimbursement Scenario
7.5.4.3. Competitive Scenario
7.5.4.4. Argentina Ambulatory Surgery Centers Market, 2021 - 2033
7.6. MEA
7.6.1. MEA Ambulatory Surgery Centers Market, 2021 - 2033
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Regulatory Framework & Reimbursement Scenario
7.6.2.3. Competitive Scenario
7.6.2.4. South Africa Ambulatory Surgery Centers Market, 2021 - 2033
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory Framework & Reimbursement Scenario
7.6.3.3. Competitive Scenario
7.6.3.4. Saudi Arabia Ambulatory Surgery Centers Market, 2021 - 2033
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory Framework & Reimbursement Scenario
7.6.4.3. Competitive Scenario
7.6.4.4. UAE Ambulatory Surgery Centers Market, 2021 - 2033
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory Framework & Reimbursement Scenario
7.6.5.3. Competitive Scenario
7.6.5.4. Kuwait Ambulatory Surgery Centers Market, 2021 - 2033
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.2.1. Mergers & Acquisitions
8.2.2. Collaborations
8.2.3. New Service Launches
8.3. Participant’s Overview
8.3.1. Envision Healthcare Corporation
8.3.1.1. Overview
8.3.1.2. Financial Performance
8.3.1.3. Service Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Surgery Partners
8.3.2.1. Overview
8.3.2.2. Financial Performance
8.3.2.3. Service Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Tenet Healthcare Corporation
8.3.3.1. Overview
8.3.3.2. Financial Performance
8.3.3.3. Service Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Pediatrix Medical Group
8.3.4.1. Overview
8.3.4.2. Financial Performance
8.3.4.3. Service Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Teamhealth
8.3.5.1. Overview
8.3.5.2. Service Benchmarking
8.3.5.3. Strategic Initiatives
8.3.6. Unitedhealth Group
8.3.6.1. Overview
8.3.6.2. Financial Performance
8.3.6.3. Service Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Quorum Health Corporation
8.3.7.1. Overview
8.3.7.2. Financial Performance
8.3.7.3. Service Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. NOVENA GLOBAL HEALTHCARE GROUP, INC.
8.3.8.1. Overview
8.3.8.2. Service Benchmarking
8.3.8.3. Strategic Initiatives
8.3.9. Community Health Systems, Inc.
8.3.9.1. Overview
8.3.9.2. Financial Performance
8.3.9.3. Service Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Terveystalo
8.3.10.1. Overview
8.3.10.2. Financial Performance
8.3.10.3. Service Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. Surgcenter Development
8.3.11.1. Overview
8.3.11.2. Service Benchmarking
8.3.11.3. Strategic Initiatives
8.3.12. Healthway Medical Group
8.3.12.1. Overview
8.3.12.2. Financial Performance
8.3.12.3. Service Benchmarking
8.3.12.4. Strategic Initiatives
8.3.13. Prospect Medical Group
8.3.13.1. Overview
8.3.13.2. Service Benchmarking
8.3.13.3. Strategic Initiatives
8.3.14. Group Eifelhöhen-Klinik AG
8.3.14.1. Overview
8.3.14.2. Service Benchmarking
8.3.15. Edward-Elmhurst Health
8.3.15.1. Overview
8.3.15.2. Service Benchmarking
8.3.15.3. Strategic Initiatives